Expression of sex hormone-binding globulin mRNA in uterine leiomyoma, myometrium and endometrium of human subjects

Gynecological Endocrinology

Volumn 9, Issue 4, 1995, Pages 317-323

  Misao, R ^a   Nakanishi, Y ^a   Fujimoto, J ^a   Tamaya, T ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

MRNA; Sex Hormone Binding Globulin; Uterine Leiomyoma

Indexed keywords

ESTROGEN; MESSENGER RNA; SEX HORMONE BINDING GLOBULIN; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; MENSTRUAL CYCLE; MESSENGER RNA SYNTHESIS; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TUMOR GROWTH; UTERUS MYOMA;

ADULT; BASE SEQUENCE; BLOTTING, SOUTHERN; ENDOMETRIUM; FEMALE; GENE EXPRESSION; HUMANS; LEIOMYOMA; MOLECULAR SEQUENCE DATA; MYOMETRIUM; POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SEX HORMONE-BINDING GLOBULIN; UTERINE NEOPLASMS; UTERUS;

EID: 0029561310     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599509160466     Document Type: Article

References (37)

1. Myomas of the uterus in pregnancy: ultrasonographic follow-up
2. Towards removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase
3. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist
4. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata
5. A randomised, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment prior to myomectomy
6. Estradiol-17 beta, progesterone and 5-alpha-dihydrotestosterone receptors of uterine myometrium and myoma in the human subject
7. Unconjugated steroids in leiomyomas and tumor bearing myometrium
8. Leiomyomas: steroid receptor content – variation within normal menstrual cycles
9. Disorders of the uterine corpus
10. Uterine fibroids: a clinical review
11. A recognition system for sex hormone binding protein-estradiol complex in human decidual endometrium plasma membranes
12. Testosterone–estradiol-binding globulin binds to human prostatic cell membranes
13. Immunocytochemical localization of the sex steroid binding plasma protein
14. Testosterone–estradiol binding globulin by a human hepatoma-derived cell line
15. Cellular distribution and hormonal regulation of h-SBP
16. Immunohistochemical localization of sex hormone binding globulin in normal and neoplastic breast tissue
17. Effects of hormones on SBP mRNA levels in human cancer cells
18. Effects of sex hormone binding globulin (SHBG) on human prostatic carcinoma
19. Sex hormone-binding globulin mRNA levels in human endometrium
20. Dating the endometrial biopsy
21. Expression of sex hormone-binding globulin mRNA in human endometrial cancers
22. The cDNA-deduced primary structure of human sex hormone-binding globulin and location of its steroid-binding domain
23. Construction of recombinant RNA templates for use as internal standards in quantitative RT–PCR
24. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
25. Sex steroid binding plasma protein
26. Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3′5′-monophosphate
27. The serum transport of steroid hormones
28. Sex hormone binding globulin: origin, function and clinical significance
29. Plasma insulin-like growth factor-I, CA-125, estrogen, and progesterone in women with leiomyomas
30. Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues
31. Comparison of cellular levels of steroid receptors in uterine leiomyoma and myometrium
32. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas
33. A randomized, double blind trial to a gonadotropin-releasing hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri
34. Regression of uterine leiomyomata in response to the antiprogesterone RU 486
35. The effect of progestins on the mitotic activity of uterine fibromyomas
36. Mitotic activity in uterine leiomyomas during the menstrual cycle
37. Cytogenetic abnormalities in uterine leiomyomata